Marjolein Je Greuter

11PUBLICATIONS
32CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisSensory processes, perception and performance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 14, 2026
Personalized risk estimates of advanced neoplasia development in individuals with a family history of colorectal cancer.

|Nov 10, 2025
CtDNA-guided de-escalation of adjuvant chemotherapy in stage III colon cancer: early model-based evaluation of cost-effectiveness.

Haoyue Wang, Astrid Kramer, Marjolein J E Greuter

|Aug 23, 2024
Early evaluation of the effectiveness and cost-effectiveness of ctDNA-guided selection for adjuvant chemotherapy in stage II colon cancer.

Astrid Kramer, Marjolein J E Greuter, Suzanna J Schraa

|Feb 16, 2024
Cumulative Incidence, Risk Factors, and Overall Survival of Disease Recurrence after Curative Resection of Stage II-III Colorectal Cancer: A Population-based Study.

Tara C Boute, Hidde Swartjes, Marjolein J E Greuter

|Feb 01, 2022
Prioritisation of colonoscopy services in colorectal cancer screening programmes to minimise impact of COVID-19 pandemic on predicted cancer burden: A comparative modelling study.

Francine van Wifferen, Lucie de Jonge, Joachim Worthington

|Jul 19, 2021
Clinical Validation of a Multitarget Fecal Immunochemical Test for Colorectal Cancer Screening : A Diagnostic Test Accuracy Study.

Willemijn de Klaver, Pieter H A Wisse, Francine van Wifferen

Pageof 2

Frequent Collaborators

6 joint publications

Veerle M H Coupé

3 joint publications

Geraldine R Vink

2 joint publications

Gabrielle Jongeneel

2 joint publications

Astrid Kramer